The disappearance pattern of prostate-specific antigen frorn serum after a Standard radical prostatectomy was studied in eight patients with cancer confined to the prostate. The results were used to plot an elimination curve and calculate the best fit. A biphasic pattern was found with an average biological half-life of l .63 hours in the -phase, and 4.63 days in the ß-phase. Based on these results it is concluded that determination of prostatespecific antigen concentrations less than one month after a Standard radical prostato-vesiculectomy has no value for the detection or exclusion of residual malignant processes.
Introduction
In 1971, a gamma seminoprotein was detected (1) in seminal plasma, and subsequently isolated and characterized by Li (2) and Sensabaugh (3) . In 1979 Wang (4) purified this protein from natural prostate tissue and named it prostate-specific antigen. After the introduction of commercial kits for the determination of prostatespecific antigen, prostatic acid phosphatase was replaced by prostate-specific antigen äs a tumour marker for prostate cancer (5, 6) . After radical prostatectomy äs a treatment for localized cancer, the absence of residual tumour (pT 2 -3N 0 M 0 ) is indicated by a decrease of serum prostate-specific antigen until it is undetectable by the current generation of immunoassays for prostate-specific antigen (6) . In view of differences in the öbserved biological washout patterns and disappearance time of prostate-specific antigen after a Standard radical prostatectomy, we initiated the present study to determine the biological half-life of prostate-specific antigen.
Methods and Patients
Prostate-specific antigen was measured by a solid-phase two-site immunoenzymatic assay employing two monoclonal antibodies. We used a commercial kit, Tandem R-E, from Hybritech (Hybritech Ine, San Diego CA, USA), according to the instructions of the manufacturer. The colorimetric measurements were performed on a Photon II spectrophotometer.
Prostate-specific antigen excretion pattems were followed in eight patients ranging from 59 to 75 years, suffering from prostatic cancer. The prostates were removed surgically, together with the seminal vesicles. In all eight patients the cancer was confined to the prostate; the bone scan was negative, and there was no lymph node involvement at lymphadenectomy (pT 2 -3NoM 0 ). The final pathological stage and grade was pT 2 G 2 (n = 2), pT 3 G 2 (n = 4) and pT 3 G 3 (n = 2), respectively. During follow-up the prostate-specific antigen concentration remained for at least one year after surgical Intervention within the female ränge; during this time there was no evidence ofdinical recurrence, based on digital rectal examination, trans rectal ultra sonography of the prostate, bone-scan and ehest X-ray. Venous blood was collected according to the following scheine: before the Intervention two samples were taken at 9 a. m. with a time interval of one day. The actual moment of removal of the prostate was ealled T 0 . During and after the Intervention, blood was collected every hour until two hours after T 0 , followed by collection at 3, 6, 9 and 12 hours after T 0 . During the following ten days one blood sample was taken each day, always at 9 a. m. Until analysis all the serum samples were stored at -20 °C. Prostate-specific antigen was determined when all the samples from one patient were available.
For the statistical evaluation of the data we used a Computer program ealled PCNONLIN NONUNEAR ESTIMATION from Statistical Consulting Ine (Lexington, Kentucky, USA), which is able to choose the right form of elimination through best fit of the elimination curves of the individual patients (one, two or three compartment model).
Results and Discussion
During the surgical extirpation of the prostate, prostatespecific antigen concentrations were increased to between three and ten times their starting levels. It was noted that a biphasic disappearance curve resulted after total removal of the prostate. The mean biological halflife in the first phase ( -phase) was 1.63 hours (SD 0.69). After the first twenty-four hours the prostatespecific antigen disappearance was more gradual. In this phase (ß-phase) the biological half-life was 4.63 days (SD 2.26). The graphic fit of the disappearance is shown in figure l and the separate data of the individüal patients are shown in table l.
The correctness of fit is very high (0.997). Data are expressed äs percentage of T 0 values. In the literature several other studies have been reported but they show no general agreement äs to the disappearance rate. Our observations contradict those of Oesterling et al. (7), who found a single phase elimination with a half-life of 3.15 days (SD 0.09.) determined with a log-linear regression model. They stated that prostate-specific antigen concentrations were undetectable after 5 to 6 times the biological half-life, meaning that 16 days after the radical prostatectomy the prostate-specific antigen concentrations were in the female ränge. Stamey et al. (6) found a two-phase elimination: an -phase of 12.6 hours (SD 19.7) and a ß-phase of 2.2 days (SD 0.8). Their data were calculated from the natural log of the prostatespecific antigen concentration plotted against time. These data fitted a two compartment model of first order elimination kinetics. They also claimed that prostatespecific antigen concentrations were no longer detectable after fourteen days. The fast decline in the first phase, äs seen in our results, is probably based on comTab. l Disappearance rates, expressed äs tj/2 of prostate-specific antigen in the 8 individüal patients. plex formation between liberated prostate-specific antigen and mainly a r antichymotrypsiii (10) , and possibly other acute phase proteins such äs a2-macroglobulin. Examples of these complexes are deseribed by Chris-? tensson (11) .
There is some doubt äs to whether the Tandem-prostate-specific antigen test method determines these complexes. a 2 -Macroglobulin is known to encapsulate the target protein at complex formation (11) . This häppens in such a way that no antiserum will detect prostatespecific antigen bound to this acute phase protein. But since the concentration of these coinplexes is low (12) it is not to be expected that their presence will inflüence our results to a great extent. The performance characteristics of the Tandem-prostate-specific antigen ässay are similar to those of the Tandem^R assay (13) , and it has been reported (10) that the latter kit also detects prostate-specific antigen complexed to a^antichymo-trypsin. Therefore, it may be concluded that the Hybri- § 1.00 tech Tandem-, äs used by us, measures free prostatespecific antigen, äs well äs prostate-specific antigen bound to -antichymotrypsin. In the second phase the slow decrease of prostate-specific antigen might be due to a slow release of prostate-specific antigen from the complexes and/or their gradual disappearance from plasma. This issue will require further study.
Conclusion
In conclusion it can be stated that prostate-specific antigen disappears after radical prostatectomy in accordance with a biphasic excretion model, consisting of an aphase with a half-life of l .63 hours and a ß-phase with a half-life of 4.63 days.
Based on our results and the assumption that 6 times the half-life should elapse before a steady level has been reached, we advise that determination of prostatespecific antigen levels less than one month after a Standard radical prostato-vesiculectomy has no value for the detection or exclusion of residual malignant processes.
